ArticleKidney medicine2026
Peritoneal Dialysis Conversion as a Salvage Therapy for Refractory Intraocular Pressure Fluctuations During Hemodialysis in a Patient With End-Stage Kidney Disease.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fluctuations in intraocular pressure (IOP) during hemodialysis (HD) have been a challenging and troublesome issue, particularly in patients with impaired aqueous humor outflow. In this report, we present a case of a 72-year-old man receiving HD with a history of glaucoma who experienced worsening of IOP fluctuations during HD and subsequently achieved IOP stabilization after transitioning to peritoneal dialysis (PD). Despite medical management and surgical interventions, his IOP remained uncontrolled, and visual disturbances persisted. After the unsuccessful treatment, we considered PD as an alternative therapy owing to its theoretical potential to stabilize osmotic disequilibrium during HD. As a result, conversion to PD resulted in stabilization of IOP within normal ranges. However, the pre-existing visual damage remained irreversible. This report represents the first attempt to address IOP fluctuations by transitioning from HD to PD, offering an option for IOP regulation in patients receiving HD. Moreover, it underscores the need for early and proactive adjustments in dialysis treatment to preserve vision and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.